Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Yuntao Biotechnology is a China-based manufacturer of pharmaceutical intermediates and other fine chemical products used in drug production. The company appears to focus on process development, production, and sales of chiral intermediates such as D-(-)-alpha-phenylglycine and para-hydroxy-phenylglycine derivatives that are used in semi-synthetic penicillins and related antibiotics. Available public information points to an operating business with manufacturing operations in Shangyu/Shaoxing, Zhejiang, and a private ownership structure. While it is sometimes categorized under biotechnology or pharmaceuticals by business databases, its disclosed activity is primarily specialty chemical and API-intermediate manufacturing rather than discovery-stage therapeutic R&D. For a biotech analyst, this is best viewed as a commercial pharmaceutical-intermediates company serving the anti-infectives supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Yuntao Biotechnology.